Floatz logo

Coagulation Factor Viia Variant

Hemophilia B With Inhibitor

Catalyst BiosciencesPhase 2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

33 Active assets in the Hemophilia B With Inhibitor cohort.

Asset / SponsorPhaseRating
Eptacog Alfa
AryoGen Pharmed Co.
Phase 4A
Factor Ix
CSL Behring
Phase 4A
Benefix
Pfizer
Phase 4A
Nonacog Beta Pegol
Novo Nordisk A/S
Phase 3A
Factor Ix
CSL Behring
Phase 4BBB

View all 50 →

Same molecule, other indications

Coagulation Factor Viia Variant is also rated in:

hemophilia ADormant
B
Indicative ·
59 / 100
View asset →
factor VII deficiencyDormant
CCC
Indicative ·
48 / 100
View asset →
Glanzmann thrombastheniaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →